Biomab Egfr Uses, Dosage, Side Effects and more
| Attribute | Details |
|---|---|
| Trade Name | Biomab Egfr |
| Generic | Nimotuzumab |
| Nimotuzumab Other Names | Nimotuzumab |
| Weight | 50mg |
| Type | Injection |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Biocon Ltd |
| Available Country | India |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Biomab Egfr is an EGFR-targeting monoclonal antibody used in the treatment of squamous cell carcinomas of the head and neck and glioblastomas.
Investigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.
Biomab Egfr is also used to associated treatment for these conditions: Advanced Head and Neck Cancer, Advanced Stage Head and Neck Cancer, Glioblastoma Multiforme (GBM), High Grade Glioma (HGG), Advanced Epithelial Tumor of the Head and Neck
